CSOP Bitcoin Futures Daily (-1x) Inverse Product
07376
ChinaAMC Bitcoin ETF
03042
CSOP Bitcoin Futures ETF
03066
Samsung Bitcoin Futures Active ETF
03135
Bosera HashKey Bitcoin ETF
03008
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | 642.14%10.94B | 5.72%4.95B | 11.97%1.47B | 0.36%4.68B | -54.92%1.32B | -27.57%4.67B | 10.62%2.92B | -33.16%6.44B | -44.59%2.64B | -35.58%9.64B |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -3.24%-961.36M | ---- | -70.86%-931.16M | ---- | -45.21%-544.98M | ---- | -59.30%-375.3M | ---- | -22.12%-235.6M |
Attributable subsidiary (profit) loss | ---- | 8.03%-599.09M | ---- | 45.94%-651.38M | ---- | -37.65%-1.2B | ---- | -31.84%-875.41M | ---- | -49.34%-664M |
Impairment and provisions: | ---- | 39.13%477.3M | ---- | 93.48%343.07M | ---- | 1,963.22%177.31M | ---- | -80.37%8.59M | ---- | 268.61%43.78M |
-Impairment of property, plant and equipment (reversal) | ---- | 3.23%205.46M | ---- | --199.03M | ---- | ---- | ---- | ---- | ---- | ---- |
-Impairmen of inventory (reversal) | ---- | 9,023.89%250.18M | ---- | -94.41%2.74M | ---- | --49.02M | ---- | ---- | ---- | ---- |
-Impairment of trade receivables (reversal) | ---- | 5,908.25%160.3M | ---- | -97.92%2.67M | ---- | 1,392.79%128.29M | ---- | -77.53%8.59M | ---- | 295.92%38.24M |
-Other impairments and provisions | ---- | -200.00%-138.63M | ---- | --138.63M | ---- | ---- | ---- | ---- | ---- | 149.75%5.54M |
Revaluation surplus: | ---- | -156.94%-67.81M | ---- | 224.67%119.08M | ---- | ---95.51M | ---- | ---- | ---- | ---- |
-Derivative financial instruments fair value (increase) | ---- | -146.00%-67.81M | ---- | 320.36%147.4M | ---- | ---66.89M | ---- | ---- | ---- | ---- |
-Other fair value changes | ---- | ---- | ---- | 1.04%-28.32M | ---- | ---28.62M | ---- | ---- | ---- | ---- |
Asset sale loss (gain): | ---- | 656.32%301.54M | ---- | -52.83%39.87M | ---- | 121.56%84.51M | ---- | -206.82%-392.04M | ---- | -298.15%-127.77M |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -113.41%-392.04M | ---- | ---183.7M |
-Loss (gain) on sale of property, machinery and equipment | ---- | 656.32%301.54M | ---- | -52.83%39.87M | ---- | --84.51M | ---- | ---- | ---- | -13.26%55.93M |
Depreciation and amortization: | ---- | -1.39%8.2B | ---- | 20.67%8.32B | ---- | 25.53%6.89B | ---- | 47.09%5.49B | ---- | 54.70%3.73B |
-Depreciation | ---- | -1.39%8.2B | ---- | 20.67%8.32B | ---- | 25.53%6.89B | ---- | 47.09%5.49B | ---- | 54.70%3.73B |
Financial expense | ---- | -24.27%417.01M | ---- | 107.94%550.69M | ---- | 58.60%264.83M | ---- | 30.88%166.98M | ---- | 11.98%127.58M |
Exchange Loss (gain) | ---- | 5.24%230.68M | ---- | 423.27%219.2M | ---- | -207.15%-67.81M | ---- | 824.95%63.28M | ---- | -103.87%-8.73M |
Special items | -177.63%-3.28B | 276.52%460.41M | -9.53%4.22B | -121.51%-260.82M | 50.05%4.67B | 7,778.25%1.21B | 51.19%3.11B | 181.97%15.39M | 38.03%2.06B | -62.59%5.46M |
Operating profit before the change of operating capital | 34.45%7.66B | 7.91%13.41B | -4.80%5.7B | 9.17%12.43B | -0.77%5.99B | 7.98%11.38B | 28.39%6.03B | -15.72%10.54B | -24.90%4.7B | -27.12%12.51B |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 15.68%-4.47B | ---- | -316.57%-5.3B | ---- | -215.31%-1.27B | ---- | 257.87%1.1B | ---- | -132.15%-699.39M |
Accounts receivable (increase)decrease | ---- | -2,103.66%-2.9B | ---- | 95.52%-131.68M | ---- | 27.04%-2.94B | ---- | -6.90%-4.03B | ---- | -132.32%-3.77B |
Accounts payable increase (decrease) | ---- | 67.57%18.61B | ---- | 18.49%11.11B | ---- | 301.58%9.37B | ---- | -172.14%-4.65B | ---- | 144.58%6.45B |
Special items for working capital changes | 28.74%8.41B | ---- | 27.08%6.53B | ---- | 455.61%5.14B | ---- | 79.65%-1.45B | ---- | -2,633.60%-7.1B | ---- |
Cash from business operations | 31.40%16.07B | 36.18%24.65B | 9.93%12.23B | 9.40%18.1B | 142.58%11.13B | 457.50%16.55B | 290.60%4.59B | -79.51%2.97B | -136.82%-2.41B | -12.44%14.49B |
Other taxs | -25.32%-1.92B | -10.81%-2.31B | -16.16%-1.53B | -73.95%-2.08B | -180.82%-1.32B | 12.70%-1.2B | 43.54%-469.58M | 29.66%-1.37B | 39.82%-831.69M | 25.62%-1.95B |
Net cash from operations | 32.27%14.15B | 39.48%22.34B | 9.09%10.7B | 4.37%16.02B | 138.22%9.81B | 861.32%15.35B | 227.14%4.12B | -87.27%1.6B | -162.83%-3.24B | -9.96%12.54B |
Cash flow from investment activities | ||||||||||
Interest received - investment | 43.27%585.66M | 3.18%921.96M | -2.35%408.79M | 56.03%893.58M | 46.09%418.63M | 91.45%572.68M | 196.12%286.56M | 26.97%299.13M | -1.37%96.77M | 22.12%235.6M |
Dividend received - investment | -38.25%136.1M | 36.94%520.39M | --220.39M | -57.24%380M | ---- | 2,101.85%888.69M | ---- | --40.36M | ---- | ---- |
Loan receivable (increase) decrease | 531.43%431.43M | ---100M | ---100M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Decrease in deposits (increase) | -329.78%-1.75B | -107.91%-796.27M | -50.92%-407.44M | -324.61%-382.99M | -566.16%-269.98M | 227.22%170.51M | 755.97%57.92M | -538.20%-134.03M | 181.15%6.77M | -226.12%-21M |
Sale of fixed assets | 38.12%178.72M | -30.49%102.05M | 206.22%129.39M | -35.71%146.81M | -73.45%42.25M | 125.62%228.36M | 758.48%159.14M | 1,131.94%101.22M | -73.69%18.54M | -92.15%8.22M |
Purchase of fixed assets | 7.85%-2.08B | -62.44%-5.71B | 10.45%-2.26B | -24.09%-3.52B | -34.21%-2.53B | -0.95%-2.83B | -219.90%-1.88B | 2.30%-2.81B | 72.84%-588.19M | -24.20%-2.87B |
Selling intangible assets | ---- | ---- | ---- | ---- | ---- | -53.86%13.19M | --117.47M | --28.59M | ---- | ---- |
Purchase of intangible assets | -1.50%-4.92B | -39.45%-9.44B | -164.83%-4.84B | -107.20%-6.77B | -2.97%-1.83B | 22.06%-3.27B | 5.07%-1.78B | 9.01%-4.19B | 19.05%-1.87B | 8.45%-4.61B |
Sale of subsidiaries | ---2.64B | --577.1M | ---- | ---- | ---- | ---- | ---- | 113,841.77%1.33B | --507.14M | ---1.17M |
Acquisition of subsidiaries | ---- | 10.03%-580.55M | 12.86%-580.55M | 74.60%-645.26M | ---666.21M | ---2.54B | ---- | ---- | ---- | 48.22%-1.59B |
Cash on investment | 99.03%-15.03M | -228.96%-171.92M | -99.07%-1.55B | 84.23%-52.26M | -1,454.73%-779.59M | -645.09%-331.38M | ---50.14M | 97.69%-44.48M | ---- | -66.67%-1.93B |
Other items in the investment business | ---- | 32.88%-1.47B | ---- | -3,517.02%-2.19B | ---- | -22.09%-60.42M | ---- | -141.50%-49.49M | 99.97%-490K | 78.49%-20.49M |
Net cash from investment operations | -12.07%-10.07B | -33.09%-16.14B | -60.21%-8.99B | -69.44%-12.13B | -81.71%-5.61B | -31.84%-7.16B | -68.63%-3.09B | 49.68%-5.43B | 74.85%-1.83B | 4.66%-10.79B |
Net cash before financing | 138.30%4.08B | 59.40%6.2B | -59.21%1.71B | -52.52%3.89B | 307.52%4.2B | 313.61%8.19B | 120.33%1.03B | -319.49%-3.83B | -138.68%-5.07B | -32.99%1.75B |
Cash flow from financing activities | ||||||||||
New borrowing | 90.20%3.61B | -77.57%2.56B | -71.30%1.9B | --11.42B | --6.62B | ---- | ---- | ---- | ---- | --2.06B |
Refund | 45.51%-3.65B | 0.26%-6.8B | -1,913.03%-6.7B | ---6.82B | ---332.77M | ---- | ---- | ---- | ---- | ---1.37B |
Issuing shares | --1.52B | -98.59%121K | ---- | -71.99%8.61M | -66.91%7.98M | -99.50%30.73M | -99.61%24.1M | 859.41%6.13B | 1,278.19%6.11B | 1,695.71%639.45M |
Issuance of bonds | ---- | --1.5B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 77.11%3.41B |
Interest paid - financing | -108.42%-364.5M | -170.85%-439.43M | -65.72%-174.89M | -15.32%-162.24M | -73.97%-105.53M | -4.99%-140.69M | 10.15%-60.66M | -8.47%-134M | -16.62%-67.52M | -68.54%-123.54M |
Dividends paid - financing | ---53.24M | -7.14%-1.96B | ---- | -9.32%-1.83B | ---- | 20.96%-1.68B | ---65.07M | 24.83%-2.12B | ---- | -28.43%-2.82B |
Absorb investment income | ---- | 325.00%5.37B | 310.33%5.2B | -56.85%1.26B | --1.27B | 5,354.97%2.93B | ---- | 3,354.08%53.71M | ---- | 50.97%1.56M |
Issuance expenses and redemption of securities expenses | ---- | ---2.07B | ---2.07B | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other items of the financing business | -1.88%-72.4M | 92.68%-142.44M | 96.21%-71.06M | -1,317.62%-1.94B | -2,842.12%-1.87B | 0.02%-137.19M | 10.80%-63.7M | ---137.22M | ---71.41M | ---- |
Net cash from financing operations | 124.88%548.9M | -308.57%-2.76B | -141.80%-2.21B | 44.66%1.33B | 2,957.26%5.28B | -75.65%916.02M | -103.10%-184.72M | 113.29%3.76B | 1,538.01%5.95B | 675.59%1.76B |
Effect of rate | 211,012.82%82.33M | -99.99%7K | -99.95%39K | 267.86%114.22M | 417.57%72.09M | 70.66%-68.04M | -317.20%-22.7M | -780.80%-231.88M | -45.93%10.45M | 51.38%34.06M |
Net Cash | 1,038.11%4.63B | -34.13%3.43B | -105.21%-493.57M | -42.75%5.21B | 1,020.78%9.48B | 12,660.10%9.11B | -4.20%845.5M | -102.07%-72.49M | 150.14%882.56M | 52.60%3.51B |
Begining period cash | 10.30%36.78B | 19.02%33.34B | 19.02%33.34B | 47.62%28.01B | 47.62%28.01B | -1.58%18.98B | -1.58%18.98B | 22.52%19.28B | 22.52%19.28B | 17.31%15.74B |
Cash at the end | 26.30%41.49B | 10.30%36.78B | -12.55%32.85B | 19.02%33.34B | 89.71%37.56B | 47.62%28.01B | -1.86%19.8B | -1.58%18.98B | 44.14%20.17B | 22.52%19.28B |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.